newsfilter
← Latest News
GlobeNewswire·

IMUNON to Present at the Life Sciences Investor Forum on June 25th

LAWRENCEVILLE, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D.,